Transcat, Inc. (NASDAQ:TRNS) Shares Sold by Jane Street Group LLC

Jane Street Group LLC lowered its holdings in Transcat, Inc. (NASDAQ:TRNS) by 41.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,251 shares of the scientific and technical instruments company’s stock after selling 5,037 shares during the period. Jane Street Group LLC’s holdings in Transcat were worth $876,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in TRNS. DekaBank Deutsche Girozentrale purchased a new stake in Transcat during the 2nd quarter worth about $40,000. nVerses Capital LLC purchased a new stake in shares of Transcat during the third quarter worth approximately $60,000. Quest Partners LLC purchased a new position in Transcat in the second quarter worth approximately $109,000. US Bancorp DE raised its holdings in shares of Transcat by 15.6% in the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after purchasing an additional 209 shares in the last quarter. Finally, Captrust Financial Advisors purchased a new position in Transcat in the third quarter valued at $201,000. 98.34% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on TRNS shares. Northland Securities cut their price objective on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. HC Wainwright reiterated a “buy” rating and set a $156.00 target price on shares of Transcat in a research report on Tuesday, October 29th. Oppenheimer reissued an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Finally, Craig Hallum raised their price objective on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $130.25.

Transcat Trading Up 0.3 %

TRNS opened at $105.74 on Thursday. Transcat, Inc. has a twelve month low of $94.29 and a twelve month high of $147.12. The firm has a market cap of $972.70 million, a price-to-earnings ratio of 53.40 and a beta of 0.70. The company has a fifty day simple moving average of $106.30 and a 200 day simple moving average of $117.62.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). The company had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.41 EPS. On average, analysts forecast that Transcat, Inc. will post 1.76 earnings per share for the current fiscal year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.